Patents/Assignees

Medicenna Therapeutics Inc.

6 patents in portfolio

US12590133utility2026
IL-13/IL-4 Superkines: Immune Cell Targeting Constructs and Methods of Use Thereof
0 cites
US12404497utility2025
Uses and Methods for Oncolytic Virus Targeting of IL-4/IL-13 and Fusions Thereof
0 cites
US12338269utility2025
IL-2 Superagonists in Combination with Anti-pd-1 Antibodies
0 cites
US12274735utility2025
Il-4-fusion Formulations for Treatment of Central Nervous System (CNS) Tumors
0 cites
US11680090utility2023
Interleukin-2 Fusion Proteins and Uses Thereof
0 cites
US11542312utility2023
IL-2 Superagonists in Combination with Anti-pd-1 Antibodies
0 cites